Exploring the link between gut bacteria and spondyloarthritis
Official title: The Role of Dysbiosis of Intestinal Microbiota in the Development of Spondyloarthritis
Run by Assistance Publique - Hôpitaux de Paris · NCT04853212 · Data updated 2026-11-12
This study is testing if a specific gut bacteria called Ruminococcus gnavus is linked to spondyloarthritis by comparing patients with the condition to healthy people.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Boulogne-Billancourt) |
| Status | Recruiting |
| Started | June 14, 2021 |
| Main results expected | May 2026 |
| Study ends | May 2026 |
| Registry record updated | March 19, 2025 |
| Trial ID | NCT04853212 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults diagnosed with spondyloarthritis and those undergoing digestive endoscopy for unrelated reasons.
✕Probably not a fit
Patients who are pregnant, breastfeeding, or have taken antibiotics recently may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This case-control study investigates the role of the bacterium Ruminococcus gnavus in the development of spondyloarthritis by comparing patients with the condition to healthy controls. It involves intestinal biopsies and fecal sampling to assess the abundance of R. gnavus and its interactions with intestinal mucus and epithelial cells. The study also aims to correlate gene expression in intestinal mucus with variations in microbiota and to demonstrate immune response perturbations caused by dysbiosis.
Why it matters
Potential benefit: If successful, this study could lead to new insights into the role of gut microbiota in spondyloarthritis, potentially guiding future treatments.
How similar studies have gone: While the role of gut microbiota in various conditions has been explored, this specific investigation into R. gnavus and spondyloarthritis is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients with SPA: * Patients ⩾ 18 years; * Diagnosed as spondyloarthritis (SpA) according ASAS classification; * Affiliated to a social security scheme; * Have signed the written informed consent form. Control subjects: * Subjects ⩾ 18 years; * Subjects free of SPA and planned for a digestive endoscopy for another indication such as to explore the risk of colorectal cancer in family member; * Affiliated to a social security scheme; * Have signed the written informed consent form. Exclusion Criteria: * Subjects unable to understand the proposed study and/or sign a informed consent form; * Pregnant women or breast feeding women; * Subjects under guardianship or curatorship; * Have taken antibiotic 1 month prior to inclusion; * Presenting acute or chronic severe pathology may likely to interfere with the interpret of outcome; * Refusal of subjects to participate to the study; * Foreign patients under french AME scheme.
Where it's running
-
Service de Rhumatologie, Hôpital Ambroise Paré, APHP
Boulogne-Billancourt, France Recruiting
Study contacts
- Principal investigator: Maxime BREBAN, MD, PhD — Service de Rhumatologie, Hôpital Ambroise Paré, APHP
- Study coordinator: Maxime BREBAN, MD, PhD
- Email: maxime.breban@aphp.fr
- Phone: +33 1 49 09 56 72
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Impact of ultra-processed foods on rheumatic diseases
This study looks at how eating ultra-processed foods might affect people with chronic rheumatic diseases like rheumatoid arthritis and osteoarthritis to see if it makes their symptoms worse.
-
Digital exercise program for patients with spondyloarthritis
This study is testing a digital exercise program to see if it helps people with axial spondyloarthritis feel better compared to regular care.
-
Fecal microbiota transplantation for treating axial spondyloarthritis
This study is testing if a treatment using gut bacteria from healthy donors can help people with axial spondyloarthritis who aren't feeling better with their current medications.
-
Exploring the role of IL-23 in spondyloarthritis
This study is trying to see how a protein called IL-23 affects immune cells in people with spondyloarthritis to better understand the disease and its different types.
-
Biobank for patients with inflammatory chronic diseases and osteoporosis
This study is creating a biobank to collect samples from patients with chronic inflammatory diseases and osteoporosis to see if they can find markers that help doctors choose better treatments.
-
Gut bacteria test to predict response to biologic treatment in spondyloarthritis
This project will test whether gut bacteria in stool samples can predict if anti-TNF or anti-IL-17 biologic treatment will work for adults with spondyloarthritis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.